The Journal of Nuclear Medicine celebrates 60 years of research

December 10, 2020

Reston, Virginia--The Journal of Nuclear Medicine (JNM) has issued a special supplement commemorating six decades of leadership in the field of nuclear medicine, molecular imaging and therapy.

The supplement features a collection of the most influential and frequently cited manuscripts in JNM's history, representing seminal discoveries and scientific contributions that shaped the future of medicine. Invited perspectives from world leaders in nuclear medicine, molecular imaging, and theranostics explain why each of these articles had such an enormous impact.

Highlights include milestone articles on the invention of the Anger camera, the creation of positron emission tomography (PET) and 18F-FDG, the development of fusion PET/CT, the introduction of FDG PET-based response criteria in solid tumors, and many more landmark papers that have shaped the history of nuclear medicine.

Moving from the past to the present and beyond, the special issue concludes with the JNM associate editors' views on the most promising future applications of nuclear medicine. "We hope to demonstrate that the field not only is highly relevant for diagnosing and understanding the pathophysiology of human diseases but also is increasingly becoming an integral part of patient management," they said.

"Our collective success is rooted in the research that scientists from around the globe submit to JNM, the tireless efforts of reviewers and editorial board members, and the commitment and interest of readers," said JNM Editor-in-Chief Johannes Czernin, MD. "Substantial credit for the success of JNM also goes to its past editors, who each made unique contributions to establish JNM as the world's leading journal on nuclear medicine and molecular imaging."
Past JNM editors include George Thoma, MD (1960-1969), Belton Burrows, MD (1970-1974), Frank Deland, MD (1975-1984), Thomas Haynie, MD (1985-1989), Harry W. Strauss (1990-1993), Stanley Goldsmith, MD (1994-1998), Martin Sandler, MD (1999-2004), Heinrich Schelbert, MD (2004-2012), and Dominique Delbeke, MD, PhD (2012-2016).

Associate editors of the journal include Wolfgang A. Weber, Carolyn J. Anderson, Ramsey D. Badawi, Henryk Barthel, Frank Benge, Lisa Bodei, Irène Buvat, Marcelo DiCarli, Michael M. Graham, Jan Grimm, Ken Herrmann, Lale Kostakoglu, Jason S. Lewis, David A. Mankoff, Todd E. Peterson, Heinrich Schelbert, Heiko Schöder, Barry A. Siegel, and H. William Strauss.

The JNM 60th Anniversary Supplement is available at

Please visit the SNMMI Media Center for more information about molecular imaging and precision imaging. To schedule an interview with the researchers, please contact Rebecca Maxey at (703) 652-6772 or

About the Society of Nuclear Medicine and Molecular Imaging

The Journal of Nuclear Medicine (JNM) is the world's leading nuclear medicine, molecular imaging and theranostics journal, accessed close to 10 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field. Current and past issues of The Journal of Nuclear Medicine can be found online at

JNM is published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging--precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit

Society of Nuclear Medicine and Molecular Imaging

Related Molecular Imaging Articles from Brightsurf:

New technique offers higher resolution molecular imaging and analysis
The new approach from Northwestern Engineering could help researchers understand more complicated biomolecular interactions and characterize cells and diseases at the single-molecule level.

Molecular imaging offers insight into therapy outcomes for neuroendocrine tumor patients
A new proof-of-concept study published in the May issue of The Journal of Nuclear Medicine has demonstrated that molecular imaging can be used for identifying early response to 177Lu-DOTATATE treatment in neuroendocrine tumor patients.

Non-invasive imaging method spots cancer at the molecular level
Researchers for the first time have combined a powerful microscopy technique with automated image analysis algorithms to distinguish between healthy and metastatic cancerous tissue without relying on invasive biopsies or the use of a contrast dye.

Molecular imaging suggests smokers may have impaired neuroimmune function
Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNM MI) shows preliminary evidence that tobacco smokers may have reduced neuroimmune function compared with nonsmokers.

Novel noninvasive molecular imaging for monitoring rheumatoid arthritis
A first-in-human Phase 1/Phase II study demonstrates that intravenous administration of the radiopharmaceutical imaging agent technetium-99m (99mTc) tilmanocept promises to be a safe, well-tolerated, noninvasive means of monitoring rheumatoid arthritis disease activity.

Improving molecular imaging using a deep learning approach
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed using a new deep learning approach to image reconstruction developed by researchers at Rensselaer Polytechnic Institute.

Nanoplatform developed with three molecular imaging modalities for tumor diagnosis
Nanotechnology and biotechnology are bringing us increasingly closer to personalised cancer treatment.

Study suggests molecular imaging strategy for determining molecular classifications of NSCLC
Recent findings suggest a novel positron emission tomography (PET) imaging approach determining epidermal growth factor receptor (EGFR) mutation status for improved lung cancer patient management.

New imaging technique able to watch molecular dynamics of neurodegenerative diseases
Researchers have developed a fast and practical molecular-scale imaging technique that could let scientists view never-before-seen dynamics of biological processes involved in neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis.

Combined optical and molecular imaging could guide breast-conserving surgery
Breast-conserving surgery is the primary treatment for early-stage breast cancer, but more accurate techniques are needed to assess resection margins during surgery to avoid the need for follow-up surgeries.

Read More: Molecular Imaging News and Molecular Imaging Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to